Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jay Olson's Stock Ratings
Oppenheimer Analyst
Jay Olson is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/21/2025
Overall Average Return
6.41%
Smart Score
Overall Average Return Percentile
52nd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/27/2025 | PRTA | Buy Now | Prothena Corp | $5.64 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/15/2025 | JSPR | Buy Now | Jasper Therapeutics | $5.35 | 1114.95% | Jay Olson60% | $80 → $65 | Maintains | Outperform | Get Alert |
| 05/14/2025 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | 566.7% | Jay Olson60% | $15 → $13 | Maintains | Outperform | Get Alert |
| 05/08/2025 | RVMD | Buy Now | Revolution Medicines | $39.66 | 89.11% | Jay Olson60% | $70 → $75 | Maintains | Outperform | Get Alert |
| 05/07/2025 | IMRX | Buy Now | Immuneering | $2.50 | 740.1% | Jay Olson60% | $25 → $21 | Maintains | Outperform | Get Alert |
| 03/14/2025 | NKTR | Buy Now | Nektar Therapeutics | $8.50 | -29.41% | Jay Olson60% | → $6 | Upgrade | Perform → Outperform | Get Alert |
| 03/03/2025 | DNLI | Buy Now | Denali Therapeutics | $13.89 | 202.38% | Jay Olson60% | $50 → $42 | Maintains | Outperform | Get Alert |
| 02/07/2025 | PRTA | Buy Now | Prothena Corp | $5.64 | 999.23% | Jay Olson60% | $58 → $62 | Maintains | Outperform | Get Alert |
| 01/24/2025 | EXEL | Buy Now | Exelixis | $40.37 | -18.26% | Jay Olson60% | $41 → $33 | Downgrade | Outperform → Perform | Get Alert |
| 01/16/2025 | EXEL | Buy Now | Exelixis | $40.37 | 1.56% | Jay Olson60% | $38 → $41 | Maintains | Outperform | Get Alert |
| 01/13/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 334.74% | Jay Olson60% | $60 → $40 | Maintains | Outperform | Get Alert |
| 12/11/2024 | QTTB | Buy Now | Q32 Bio | $1.55 | 1190.32% | Jay Olson60% | $80 → $20 | Maintains | Outperform | Get Alert |
| 11/18/2024 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | 669.27% | Jay Olson60% | $33 → $15 | Maintains | Outperform | Get Alert |
| 11/11/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 552.12% | Jay Olson60% | $70 → $60 | Maintains | Outperform | Get Alert |
| 10/31/2024 | BIIB | Buy Now | Biogen | $127.04 | 100.72% | Jay Olson60% | $270 → $255 | Maintains | Outperform | Get Alert |
| 10/30/2024 | SAGE | Buy Now | Sage Therapeutics | $9.22 | -13.23% | Jay Olson60% | $9 → $8 | Maintains | Perform | Get Alert |
| 10/30/2024 | INCY | Buy Now | Incyte | $68.25 | 20.15% | Jay Olson60% | $81 → $82 | Maintains | Outperform | Get Alert |
| 10/28/2024 | RVMD | Buy Now | Revolution Medicines | $39.66 | 51.29% | Jay Olson60% | $55 → $60 | Maintains | Outperform | Get Alert |
| 10/23/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | 22.49% | Jay Olson60% | $375 → $350 | Maintains | Outperform | Get Alert |
| 10/17/2024 | GLTO | Buy Now | Galecto | $3.32 | 201.2% | Jay Olson60% | $9 → $10 | Maintains | Outperform | Get Alert |
| 09/25/2024 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 429.55% | Jay Olson60% | $138 → $138 | Reiterates | Outperform → Outperform | Get Alert |
| 09/23/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | → $6 | Upgrade | Perform → Outperform | Get Alert |
| 08/14/2024 | PRTA | Buy Now | Prothena Corp | $5.64 | 999.23% | Jay Olson60% | $66 → $62 | Maintains | Outperform | Get Alert |
| 08/14/2024 | GANX | Buy Now | Gain Therapeutics | $1.80 | 344.44% | Jay Olson60% | → $8 | Assumes | → Outperform | Get Alert |
| 08/12/2024 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | 1592.39% | Jay Olson60% | $40 → $33 | Maintains | Outperform | Get Alert |
| 08/07/2024 | BCYC | Buy Now | Bicycle Therapeutics | $7.42 | 546.9% | Jay Olson60% | $48 → $48 | Maintains | Outperform | Get Alert |
| 08/07/2024 | AMGN | Buy Now | Amgen | $289.33 | 31.34% | Jay Olson60% | $380 → $380 | Maintains | Outperform | Get Alert |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 73.05% | Jay Olson60% | $216 → $219 | Maintains | Outperform | Get Alert |
| 07/30/2024 | EXEL | Buy Now | Exelixis | $40.37 | -28.16% | Jay Olson60% | $29 → $29 | Maintains | Outperform | Get Alert |
| 07/26/2024 | INCY | Buy Now | Incyte | $68.25 | 18.68% | Jay Olson60% | $84 → $81 | Maintains | Outperform | Get Alert |
| 07/16/2024 | RVMD | Buy Now | Revolution Medicines | $39.66 | 38.68% | Jay Olson60% | $45 → $55 | Maintains | Outperform | Get Alert |
| 06/18/2024 | EDIT | Buy Now | Editas Medicine | $2.21 | 442.99% | Jay Olson60% | $12 → $12 | Maintains | Perform | Get Alert |
| 06/10/2024 | GLTO | Buy Now | Galecto | $3.32 | 171.08% | Jay Olson60% | $10 → $9 | Maintains | Outperform | Get Alert |
| 05/15/2024 | VYGR | Buy Now | Voyager Therapeutics | $3.09 | 482.52% | Jay Olson60% | $18 → $18 | Maintains | Outperform | Get Alert |
| 05/15/2024 | STRO | Buy Now | Sutro Biopharma | $0.80 | 1148.6% | Jay Olson60% | $10 → $10 | Maintains | Outperform | Get Alert |
| 05/10/2024 | CRSP | Buy Now | CRISPR Therapeutics | $44.30 | 114.45% | Jay Olson60% | $102 → $95 | Maintains | Outperform | Get Alert |
| 05/06/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | -16.34% | Jay Olson60% | $19 → $19 | Maintains | Perform | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 70.68% | Jay Olson60% | $200 → $216 | Maintains | Outperform | Get Alert |
| 04/29/2024 | BIIB | Buy Now | Biogen | $127.04 | 112.53% | Jay Olson60% | $270 → $270 | Maintains | Outperform | Get Alert |
| 04/24/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 58.04% | Jay Olson60% | $200 → $200 | Maintains | Outperform | Get Alert |
| 04/24/2024 | INCY | Buy Now | Incyte | $68.25 | 23.08% | Jay Olson60% | $92 → $84 | Maintains | Outperform | Get Alert |
| 04/19/2024 | BIIB | Buy Now | Biogen | $127.04 | 112.53% | Jay Olson60% | $290 → $270 | Maintains | Outperform | Get Alert |
| 04/18/2024 | SAGE | Buy Now | Sage Therapeutics | $9.22 | 84.38% | Jay Olson60% | $25 → $17 | Maintains | Perform | Get Alert |
| 04/12/2024 | RVMD | Buy Now | Revolution Medicines | $39.66 | 13.46% | Jay Olson60% | $43 → $45 | Maintains | Outperform | Get Alert |
| 04/12/2024 | SKYE | Buy Now | Skye Bioscience | $2.16 | 1057.41% | Jay Olson60% | → $25 | Initiates | → Outperform | Get Alert |
| 04/11/2024 | QTTB | Buy Now | Q32 Bio | $1.55 | 3125.81% | Jay Olson60% | → $50 | Initiates | → Outperform | Get Alert |
| 04/09/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $37.40 | 100.53% | Jay Olson60% | $72 → $75 | Maintains | Outperform | Get Alert |
| 04/03/2024 | STRO | Buy Now | Sutro Biopharma | $0.80 | 1148.6% | Jay Olson60% | $10 → $10 | Maintains | Outperform | Get Alert |
| 03/28/2024 | STRO | Buy Now | Sutro Biopharma | $0.80 | 1148.6% | Jay Olson60% | → $10 | Maintains | Outperform | Get Alert |
| 03/27/2024 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 429.55% | Jay Olson60% | $116 → $138 | Maintains | Outperform | Get Alert |
| 03/27/2024 | STRO | Buy Now | Sutro Biopharma | $0.80 | 1148.6% | Jay Olson60% | $10 → $10 | Maintains | Outperform | Get Alert |
| 03/27/2024 | CGTX | Buy Now | Cognition Therapeutics | $0.27 | 3245.72% | Jay Olson60% | $9 → $9 | Maintains | Outperform | Get Alert |
| 03/26/2024 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 429.55% | Jay Olson60% | $116 → $138 | Maintains | Outperform | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | 31.24% | Jay Olson60% | $320 → $375 | Maintains | Outperform | Get Alert |
| 03/13/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 58.04% | Jay Olson60% | $170 → $200 | Maintains | Outperform | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | -16.34% | Jay Olson60% | $25 → $19 | Maintains | Perform | Get Alert |
| 03/07/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | $9 → $9 | Maintains | Perform | Get Alert |
| 03/07/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.35 | 1395.33% | Jay Olson60% | $80 → $80 | Maintains | Outperform | Get Alert |
| 03/06/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $37.40 | 92.51% | Jay Olson60% | $65 → $72 | Maintains | Outperform | Get Alert |
| 03/05/2024 | IMRX | Buy Now | Immuneering | $2.50 | 900.12% | Jay Olson60% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 03/05/2024 | ETNB | Buy Now | 89bio | $10.16 | — | Jay Olson60% | — | Maintains | Perform | Get Alert |
| 03/01/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | 11.99% | Jay Olson60% | $300 → $320 | Maintains | Outperform | Get Alert |
| 02/28/2024 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 345.13% | Jay Olson60% | $46 → $116 | Maintains | Outperform | Get Alert |
| 02/26/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $37.40 | 73.8% | Jay Olson60% | $63 → $65 | Reinstates | → Outperform | Get Alert |
| 02/20/2024 | PRTA | Buy Now | Prothena Corp | $5.64 | 1318.36% | Jay Olson60% | $98 → $80 | Maintains | Outperform | Get Alert |
| 02/14/2024 | BIIB | Buy Now | Biogen | $127.04 | 128.27% | Jay Olson60% | $295 → $290 | Maintains | Outperform | Get Alert |
| 02/05/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 10.08% | Jay Olson60% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 02/01/2024 | AMGN | Buy Now | Amgen | $289.33 | 20.97% | Jay Olson60% | → $350 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | BIIB | Buy Now | Biogen | $127.04 | 132.21% | Jay Olson60% | → $295 | Reiterates | Outperform → Outperform | Get Alert |
| 12/18/2023 | BIIB | Buy Now | Biogen | $127.04 | 132.21% | Jay Olson60% | $280 → $295 | Maintains | Outperform | Get Alert |
| 11/30/2023 | BIVI | Buy Now | BioVie | $1.09 | 358.72% | Jay Olson60% | $12 → $5 | Maintains | Outperform | Get Alert |
| 11/22/2023 | ENTA | Buy Now | Enanta Pharma | $7.18 | 192.48% | Jay Olson60% | $25 → $21 | Maintains | Perform | Get Alert |
| 11/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 660.8% | Jay Olson60% | $80 → $70 | Maintains | Outperform | Get Alert |
| 10/25/2023 | AMGN | Buy Now | Amgen | $289.33 | 7.14% | Jay Olson60% | $300 → $310 | Maintains | Outperform | Get Alert |
| 10/23/2023 | RVMD | Buy Now | Revolution Medicines | $39.66 | 8.42% | Jay Olson60% | $40 → $43 | Maintains | Outperform | Get Alert |
| 10/20/2023 | AMGN | Buy Now | Amgen | $289.33 | 3.69% | Jay Olson60% | $290 → $300 | Maintains | Outperform | Get Alert |
| 10/09/2023 | AMGN | Buy Now | Amgen | $289.33 | 0.23% | Jay Olson60% | $280 → $290 | Maintains | Outperform | Get Alert |
| 10/06/2023 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 30.38% | Jay Olson60% | $160 → $165 | Maintains | Outperform | Get Alert |
| 10/06/2023 | IMGN | Buy Now | Immunogen | — | — | Jay Olson60% | → $16 | Initiates | → Perform | Get Alert |
| 10/06/2023 | STRO | Buy Now | Sutro Biopharma | $0.80 | 1148.6% | Jay Olson60% | → $10 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $40.37 | -28.16% | Jay Olson60% | $25 → $29 | Maintains | Outperform | Get Alert |
| 08/21/2023 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 21.69% | Jay Olson60% | $150 → $154 | Maintains | Outperform | Get Alert |
| 08/11/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | → $14 | Downgrade | Outperform → Perform | Get Alert |
| 08/10/2023 | CRSP | Buy Now | CRISPR Therapeutics | $44.30 | 130.25% | Jay Olson60% | → $102 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $56 → $62 | Maintains | Outperform | Get Alert |
| 08/09/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | -0.26% | Jay Olson60% | $350 → $285 | Maintains | Outperform | Get Alert |
| 08/09/2023 | ENTA | Buy Now | Enanta Pharma | $7.18 | 248.19% | Jay Olson60% | $30 → $25 | Maintains | Perform | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $9.22 | 116.92% | Jay Olson60% | $24 → $20 | Maintains | Perform | Get Alert |
| 08/07/2023 | VYGR | Buy Now | Voyager Therapeutics | $3.09 | 417.8% | Jay Olson60% | → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | BIIB | Buy Now | Biogen | $127.04 | 128.27% | Jay Olson60% | $360 → $290 | Maintains | Outperform | Get Alert |
| 08/07/2023 | SAGE | Buy Now | Sage Therapeutics | $9.22 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 08/03/2023 | EDIT | Buy Now | Editas Medicine | $2.21 | 442.99% | Jay Olson60% | → $12 | Reiterates | Perform → Perform | Get Alert |
| 08/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 10.08% | Jay Olson60% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 08/02/2023 | RVMD | Buy Now | Revolution Medicines | $39.66 | 0.86% | Jay Olson60% | $35 → $40 | Maintains | Outperform | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 18.53% | Jay Olson60% | → $150 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | INCY | Buy Now | Incyte | $68.25 | 34.8% | Jay Olson60% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | GLTO | Buy Now | Galecto | $3.32 | 261.45% | Jay Olson60% | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 07/31/2023 | EXEL | Buy Now | Exelixis | $40.37 | -38.07% | Jay Olson60% | → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 10.08% | Jay Olson60% | $23 → $25 | Maintains | Perform | Get Alert |
| 07/25/2023 | AMGN | Buy Now | Amgen | $289.33 | -3.22% | Jay Olson60% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 07/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 1.28% | Jay Olson60% | $20 → $23 | Maintains | Perform | Get Alert |
| 06/20/2023 | GLTO | Buy Now | Galecto | $3.32 | 261.45% | Jay Olson60% | → $12 | Initiates | → Outperform | Get Alert |
| 06/12/2023 | BIIB | Buy Now | Biogen | $127.04 | 183.38% | Jay Olson60% | $350 → $360 | Maintains | Outperform | Get Alert |
| 06/06/2023 | DNLI | Buy Now | Denali Therapeutics | $13.89 | 389.56% | Jay Olson60% | $70 → $68 | Maintains | Outperform | Get Alert |
| 05/18/2023 | AMGN | Buy Now | Amgen | $289.33 | -3.22% | Jay Olson60% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 05/17/2023 | BIVI | Buy Now | BioVie | $1.09 | 1000.92% | Jay Olson60% | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 53.49% | Jay Olson60% | $35 → $40 | Maintains | Outperform | Get Alert |
| 05/16/2023 | JSPR | Buy Now | Jasper Therapeutics | $5.35 | 49.53% | Jay Olson60% | → $8 | Reinstates | Outperform → Outperform | Get Alert |
| 05/16/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Jay Olson60% | $14 → $16 | Maintains | Outperform | Get Alert |
| 05/16/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | 22.49% | Jay Olson60% | $300 → $350 | Maintains | Outperform | Get Alert |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | → $60 | Reiterates | Perform → Perform | Get Alert |
| 05/11/2023 | ENTA | Buy Now | Enanta Pharma | $7.18 | 317.83% | Jay Olson60% | $50 → $30 | Reiterates | Perform → Perform | Get Alert |
| 05/11/2023 | ETNB | Buy Now | 89bio | $10.16 | 195.28% | Jay Olson60% | → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | RVMD | Buy Now | Revolution Medicines | $39.66 | -11.75% | Jay Olson60% | → $35 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | EDIT | Buy Now | Editas Medicine | $2.21 | 442.99% | Jay Olson60% | → $12 | Reiterates | → Perform | Get Alert |
| 05/09/2023 | CGTX | Buy Now | Cognition Therapeutics | $0.27 | 3245.72% | Jay Olson60% | → $9 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jay Olson60% | → $280 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 878.18% | Jay Olson60% | $93 → $90 | Maintains | Outperform | Get Alert |
| 05/08/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.42 | 641.24% | Jay Olson60% | → $55 | Reiterates | → Outperform | Get Alert |
| 05/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 18.53% | Jay Olson60% | → $150 | Reiterates | → Outperform | Get Alert |
| 04/27/2023 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 34.31% | Jay Olson60% | → $35 | Reiterates | → Outperform | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $127.04 | 155.82% | Jay Olson60% | $310 → $325 | Maintains | Outperform | Get Alert |
| 04/25/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | $12 → $14 | Maintains | Outperform | Get Alert |
| 04/25/2023 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 34.31% | Jay Olson60% | $30 → $35 | Maintains | Outperform | Get Alert |
| 04/24/2023 | AMGN | Buy Now | Amgen | $289.33 | 0.23% | Jay Olson60% | $292 → $290 | Maintains | Outperform | Get Alert |
| 03/28/2023 | VKTX | Buy Now | Viking Therapeutics | $26.06 | 15.12% | Jay Olson60% | $20 → $30 | Maintains | Outperform | Get Alert |
| 03/24/2023 | CGTX | Buy Now | Cognition Therapeutics | $0.27 | 3245.72% | Jay Olson60% | → $9 | Reiterates | → Outperform | Get Alert |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $210 → $229 | Maintains | Outperform | Get Alert |
| 03/10/2023 | VYGR | Buy Now | Voyager Therapeutics | $3.09 | 353.07% | Jay Olson60% | → $14 | Initiates | → Outperform | Get Alert |
| 03/07/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Jay Olson60% | $10 → $12 | Maintains | Outperform | Get Alert |
| 03/06/2023 | NKTR | Buy Now | Nektar Therapeutics | $8.50 | -64.71% | Jay Olson60% | $5 → $3 | Maintains | Perform | Get Alert |
| 03/02/2023 | DNLI | Buy Now | Denali Therapeutics | $13.89 | 403.96% | Jay Olson60% | $85 → $70 | Maintains | Outperform | Get Alert |
| 03/01/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | -11.93% | Jay Olson60% | $17 → $20 | Maintains | Perform | Get Alert |
| 02/28/2023 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $180 → $210 | Maintains | Outperform | Get Alert |
| 02/28/2023 | RVMD | Buy Now | Revolution Medicines | $39.66 | -11.75% | Jay Olson60% | $30 → $35 | Maintains | Outperform | Get Alert |
| 02/27/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | 4.99% | Jay Olson60% | $250 → $300 | Maintains | Outperform | Get Alert |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 910.78% | Jay Olson60% | $115 → $93 | Maintains | Outperform | Get Alert |
| 02/23/2023 | CRSP | Buy Now | CRISPR Therapeutics | $44.30 | 130.38% | Jay Olson60% | $110 → $102.06 | Maintains | Outperform | Get Alert |
| 02/21/2023 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $178 → $180 | Maintains | Outperform | Get Alert |
| 02/21/2023 | ETNB | Buy Now | 89bio | $10.16 | 77.17% | Jay Olson60% | $12 → $18 | Maintains | Outperform | Get Alert |
| 02/17/2023 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $178 → $180 | Maintains | Outperform | Get Alert |
| 02/16/2023 | BIIB | Buy Now | Biogen | $127.04 | 144.02% | Jay Olson60% | $320 → $310 | Maintains | Outperform | Get Alert |
| 02/15/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | -25.14% | Jay Olson60% | $16 → $17 | Maintains | Perform | Get Alert |
| 02/14/2023 | BIVI | Buy Now | BioVie | $1.09 | 1000.92% | Jay Olson60% | → $12 | Reiterates | → Outperform | Get Alert |
| 02/14/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 02/10/2023 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $188 → $178 | Maintains | Outperform | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $289.33 | 1.61% | Jay Olson60% | $312 → $294 | Maintains | Outperform | Get Alert |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | -12.5% | Jay Olson60% | $170 → $250 | Maintains | Outperform | Get Alert |
| 12/08/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $85 → $60 | Maintains | Perform | Get Alert |
| 12/06/2022 | AMGN | Buy Now | Amgen | $289.33 | 7.14% | Jay Olson60% | $300 → $310 | Maintains | Outperform | Get Alert |
| 11/29/2022 | CINC | Buy Now | CinCor Pharma | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $2.21 | 442.99% | Jay Olson60% | $28 → $12 | Downgrade | Outperform → Perform | Get Alert |
| 11/14/2022 | JSPR | Buy Now | Jasper Therapeutics | $5.35 | 49.53% | Jay Olson60% | $21 → $8 | Maintains | Outperform | Get Alert |
| 11/14/2022 | BIIB | Buy Now | Biogen | $127.04 | 147.95% | Jay Olson60% | $300 → $315 | Maintains | Outperform | Get Alert |
| 10/31/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 10/28/2022 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $208 → $188 | Maintains | Outperform | Get Alert |
| 10/21/2022 | RVMD | Buy Now | Revolution Medicines | $39.66 | -24.36% | Jay Olson60% | → $30 | Initiates | → Outperform | Get Alert |
| 10/13/2022 | RLMD | Buy Now | Relmada Therapeutics | $0.67 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 09/29/2022 | PRTA | Buy Now | Prothena Corp | $5.64 | 1850.25% | Jay Olson60% | $100 → $110 | Maintains | Outperform | Get Alert |
| 08/10/2022 | ENTA | Buy Now | Enanta Pharma | $7.18 | 721.73% | Jay Olson60% | $53 → $59 | Maintains | Perform | Get Alert |
| 08/01/2022 | ENTA | Buy Now | Enanta Pharma | $7.18 | 638.16% | Jay Olson60% | $45 → $53 | Maintains | Perform | Get Alert |
| 07/21/2022 | CINC | Buy Now | CinCor Pharma | — | — | Jay Olson60% | $30 → $35 | Maintains | Outperform | Get Alert |
| 07/18/2022 | BIIB | Buy Now | Biogen | $127.04 | 81.05% | Jay Olson60% | $225 → $230 | Maintains | Outperform | Get Alert |
| 06/30/2022 | ETNB | Buy Now | 89bio | $10.16 | 47.64% | Jay Olson60% | $40 → $15 | Maintains | Outperform | Get Alert |
| 06/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $44.30 | 175.4% | Jay Olson60% | $150 → $122 | Maintains | Outperform | Get Alert |
| 06/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | -16.34% | Jay Olson60% | $23 → $19 | Maintains | Perform | Get Alert |
| 06/21/2022 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $160 → $208 | Maintains | Outperform | Get Alert |
| 06/01/2022 | AMGN | Buy Now | Amgen | $289.33 | 0.23% | Jay Olson60% | $285 → $290 | Maintains | Outperform | Get Alert |
| 05/20/2022 | ENTA | Buy Now | Enanta Pharma | $7.18 | 526.74% | Jay Olson60% | $70 → $45 | Maintains | Outperform | Get Alert |
| 05/13/2022 | ETNB | Buy Now | 89bio | $10.16 | 293.7% | Jay Olson60% | $49 → $40 | Maintains | Outperform | Get Alert |
| 05/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $44.30 | 238.6% | Jay Olson60% | $172 → $150 | Maintains | Outperform | Get Alert |
| 05/10/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | -40.5% | Jay Olson60% | $180 → $170 | Maintains | Outperform | Get Alert |
| 05/09/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 1312.92% | Jay Olson60% | $160 → $130 | Maintains | Outperform | Get Alert |
| 05/09/2022 | RLMD | Buy Now | Relmada Therapeutics | $0.67 | 9452.24% | Jay Olson60% | $75 → $64 | Maintains | Outperform | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $127.04 | 77.11% | Jay Olson60% | $240 → $225 | Maintains | Outperform | Get Alert |
| 04/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | Jay Olson60% | $45 → $55 | Downgrade | Outperform → Perform | Get Alert |
| 04/08/2022 | BIIB | Buy Now | Biogen | $127.04 | 88.92% | Jay Olson60% | $285 → $240 | Maintains | Outperform | Get Alert |
| 03/30/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Jay Olson60% | $25 → $16 | Maintains | Outperform | Get Alert |
| 03/15/2022 | BIVI | Buy Now | BioVie | $1.09 | 725.69% | Jay Olson60% | → $9 | Initiates | → Outperform | Get Alert |
| 03/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | Jay Olson60% | $38 → $45 | Maintains | Outperform | Get Alert |
| 03/09/2022 | NKTR | Buy Now | Nektar Therapeutics | $8.50 | 147.06% | Jay Olson60% | → $21 | Upgrade | Perform → Outperform | Get Alert |
| 02/25/2022 | EDIT | Buy Now | Editas Medicine | $2.21 | 2388.69% | Jay Olson60% | $80 → $55 | Maintains | Outperform | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $289.33 | -1.5% | Jay Olson60% | $272 → $285 | Maintains | Outperform | Get Alert |
| 02/07/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 1530.29% | Jay Olson60% | $145 → $150 | Upgrade | Perform → Outperform | Get Alert |
| 02/01/2022 | CINC | Buy Now | CinCor Pharma | — | — | Jay Olson60% | → $30 | Initiates | → Outperform | Get Alert |
| 12/22/2021 | BIIB | Buy Now | Biogen | $127.04 | 175.5% | Jay Olson60% | $390 → $350 | Maintains | Outperform | Get Alert |
| 12/09/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 1.28% | Jay Olson60% | $20 → $23 | Maintains | Perform | Get Alert |
| 12/08/2021 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 21.69% | Jay Olson60% | $140 → $154 | Maintains | Outperform | Get Alert |
| 12/07/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 1.28% | Jay Olson60% | $20 → $23 | Maintains | Perform | Get Alert |
| 11/24/2021 | ENTA | Buy Now | Enanta Pharma | $7.18 | 916.71% | Jay Olson60% | $55 → $73 | Maintains | Perform | Get Alert |
| 11/05/2021 | NKTR | Buy Now | Nektar Therapeutics | $8.50 | 147.06% | Jay Olson60% | $25 → $21 | Maintains | Perform | Get Alert |
| 11/05/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 1475.95% | Jay Olson60% | $160 → $145 | Maintains | Perform | Get Alert |
| 11/03/2021 | SAGE | Buy Now | Sage Therapeutics | $9.22 | 767.68% | Jay Olson60% | $84 → $80 | Maintains | Outperform | Get Alert |
| 11/03/2021 | INCY | Buy Now | Incyte | $68.25 | 59.71% | Jay Olson60% | $110 → $109 | Maintains | Outperform | Get Alert |
| 11/03/2021 | CGTX | Buy Now | Cognition Therapeutics | $0.27 | 8078.44% | Jay Olson60% | → $22 | Initiates | → Outperform | Get Alert |
| 11/02/2021 | EXEL | Buy Now | Exelixis | $40.37 | -28.16% | Jay Olson60% | $30 → $29 | Maintains | Outperform | Get Alert |
| 10/29/2021 | SGEN | Buy Now | Seagen | — | — | Jay Olson60% | $196 → $198 | Maintains | Outperform | Get Alert |
| 10/21/2021 | BIIB | Buy Now | Biogen | $127.04 | 206.99% | Jay Olson60% | $450 → $390 | Maintains | Outperform | Get Alert |
| 10/20/2021 | SAGE | Buy Now | Sage Therapeutics | $9.22 | 811.06% | Jay Olson60% | $100 → $84 | Maintains | Outperform | Get Alert |
| 10/13/2021 | FOCS | Buy Now | Focus Finl Partners | — | — | Jay Olson60% | $64 → $71 | Maintains | Outperform | Get Alert |
| 10/13/2021 | JSPR | Buy Now | Jasper Therapeutics | $5.35 | 292.52% | Jay Olson60% | → $21 | Initiates | → Outperform | Get Alert |
| 09/27/2021 | PRTA | Buy Now | Prothena Corp | $5.64 | 1672.96% | Jay Olson60% | $90 → $100 | Maintains | Outperform | Get Alert |
| 09/21/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $160 → $175 | Maintains | Perform | Get Alert |
| 09/21/2021 | DNLI | Buy Now | Denali Therapeutics | $13.89 | 511.95% | Jay Olson60% | → $85 | Initiates | → Outperform | Get Alert |
| 09/14/2021 | PRTA | Buy Now | Prothena Corp | $5.64 | 1495.66% | Jay Olson60% | $82 → $90 | Maintains | Outperform | Get Alert |
| 09/10/2021 | EDIT | Buy Now | Editas Medicine | $2.21 | 3519.91% | Jay Olson60% | $42 → $80 | Upgrade | Perform → Outperform | Get Alert |
| 08/17/2021 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Jay Olson60% | $27 → $25 | Maintains | Outperform | Get Alert |
| 08/09/2021 | PRTA | Buy Now | Prothena Corp | $5.64 | 1353.82% | Jay Olson60% | $76 → $82 | Maintains | Outperform | Get Alert |
| 08/06/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.20 | 1638.98% | Jay Olson60% | $125 → $160 | Maintains | Perform | Get Alert |
| 07/13/2021 | PRTA | Buy Now | Prothena Corp | $5.64 | 1247.45% | Jay Olson60% | $54 → $76 | Maintains | Outperform | Get Alert |
| 06/07/2021 | AMGN | Buy Now | Amgen | $289.33 | -4.26% | Jay Olson60% | $272 → $277 | Maintains | Outperform | Get Alert |
| 05/18/2021 | BIIB | Buy Now | Biogen | $127.04 | 155.82% | Jay Olson60% | $300 → $325 | Maintains | Outperform | Get Alert |
| 05/17/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $245 → $160 | Downgrade | Outperform → Perform | Get Alert |
| 05/03/2021 | AMGN | Buy Now | Amgen | $289.33 | -8.41% | Jay Olson60% | $275 → $265 | Maintains | Outperform | Get Alert |
| 04/05/2021 | AMGN | Buy Now | Amgen | $289.33 | -4.95% | Jay Olson60% | $266 → $275 | Maintains | Outperform | Get Alert |
| 03/24/2021 | FREQ | Buy Now | Frequency Therapeutics | — | — | Jay Olson60% | $68 → $20 | Maintains | Outperform | Get Alert |
| 03/01/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $260 → $255 | Maintains | Outperform | Get Alert |
| 03/01/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jay Olson60% | $135 → $148 | Maintains | Outperform | Get Alert |
| 02/25/2021 | SAGE | Buy Now | Sage Therapeutics | $9.22 | 1006.29% | Jay Olson60% | $90 → $102 | Maintains | Outperform | Get Alert |
| 02/17/2021 | CRSP | Buy Now | CRISPR Therapeutics | $44.30 | 322.12% | Jay Olson60% | $165 → $187 | Maintains | Outperform | Get Alert |
| 02/02/2021 | PRTA | Buy Now | Prothena Corp | $5.64 | 520.53% | Jay Olson60% | $25 → $35 | Maintains | Outperform | Get Alert |
| 11/11/2020 | VYGR | Buy Now | Voyager Therapeutics | $3.09 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 10/06/2020 | AMGN | Buy Now | Amgen | $289.33 | -3.22% | Jay Olson60% | $270 → $280 | Maintains | Outperform | Get Alert |
| 09/21/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $133 → $190 | Maintains | Outperform | Get Alert |
| 07/21/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 84.94% | Jay Olson60% | $53 → $42 | Maintains | Perform | Get Alert |
| 07/14/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | Jay Olson60% | → $36 | Initiates | → Outperform | Get Alert |
| 07/09/2020 | PRTA | Buy Now | Prothena Corp | $5.64 | — | Jay Olson60% | — | Upgrade | Perform → Outperform | Get Alert |
| 06/29/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Jay Olson60% | $124 → $46 | Downgrade | Outperform → Perform | Get Alert |
| 06/24/2020 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jay Olson60% | $125 → $135 | Maintains | Outperform | Get Alert |
| 06/12/2020 | BCYC | Buy Now | Bicycle Therapeutics | $7.42 | 263.88% | Jay Olson60% | → $27 | Initiates | → Outperform | Get Alert |
| 06/02/2020 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Jay Olson60% | → $23 | Initiates | → Outperform | Get Alert |
| 05/27/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 133.38% | Jay Olson60% | $48 → $53 | Maintains | Perform | Get Alert |
| 05/18/2020 | NKTR | Buy Now | Nektar Therapeutics | $8.50 | 194.11% | Jay Olson60% | $24 → $25 | Maintains | Perform | Get Alert |
| 05/01/2020 | AMGN | Buy Now | Amgen | $289.33 | -12.9% | Jay Olson60% | $250 → $252 | Maintains | Outperform | Get Alert |
| 04/28/2020 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jay Olson60% | → $125 | Initiates | → Outperform | Get Alert |
| 04/27/2020 | AMGN | Buy Now | Amgen | $289.33 | -13.59% | Jay Olson60% | $240 → $250 | Maintains | Outperform | Get Alert |
| 04/23/2020 | BIIB | Buy Now | Biogen | $127.04 | 187.31% | Jay Olson60% | $390 → $365 | Maintains | Outperform | Get Alert |
| 04/21/2020 | INCY | Buy Now | Incyte | $68.25 | 64.1% | Jay Olson60% | $90 → $112 | Maintains | Outperform | Get Alert |
| 04/13/2020 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 2.73% | Jay Olson60% | $132 → $130 | Maintains | Outperform | Get Alert |
| 04/08/2020 | SAGE | Buy Now | Sage Therapeutics | $9.22 | 442.3% | Jay Olson60% | $60 → $50 | Maintains | Outperform | Get Alert |
| 04/07/2020 | INCY | Buy Now | Incyte | $68.25 | 31.87% | Jay Olson60% | $85 → $90 | Maintains | Outperform | Get Alert |
| 04/07/2020 | MLND | Buy Now | Millendo Therapeutics | — | — | Jay Olson60% | $25 → $2 | Downgrade | Outperform → Perform | Get Alert |
| 03/30/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jay Olson60% | $129 → $105 | Maintains | Outperform | Get Alert |
| 03/26/2020 | AMGN | Buy Now | Amgen | $289.33 | -17.05% | Jay Olson60% | $250 → $240 | Maintains | Outperform | Get Alert |
| 02/06/2020 | VYGR | Buy Now | Voyager Therapeutics | $3.09 | 741.42% | Jay Olson60% | → $26 | Initiates | → Outperform | Get Alert |
| 01/13/2020 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 4.31% | Jay Olson60% | $115 → $132 | Maintains | Outperform | Get Alert |
| 01/10/2020 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Jay Olson60% | $40 → $17 | Downgrade | Outperform → Perform | Get Alert |
| 01/03/2020 | INCY | Buy Now | Incyte | $68.25 | 40.66% | Jay Olson60% | $100 → $96 | Maintains | Outperform | Get Alert |
| 12/20/2019 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | → $6 | Initiates | → Outperform | Get Alert |
| 12/09/2019 | ETNB | Buy Now | 89bio | $10.16 | 490.55% | Jay Olson60% | → $60 | Initiates | → Outperform | Get Alert |
| 12/06/2019 | SRRA | Buy Now | Sierra Oncology | — | — | Jay Olson60% | → $1.2 | Initiates | → Outperform | Get Alert |
| 11/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/25/2019 | MDCO | Buy Now | Medicines Co | — | — | Jay Olson60% | $68 → $85 | Downgrade | Outperform → Perform | Get Alert |
| 10/24/2019 | NKTR | Buy Now | Nektar Therapeutics | $8.50 | 111.76% | Jay Olson60% | → $18 | Initiates | → Perform | Get Alert |
| 10/24/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.71 | 93.75% | Jay Olson60% | → $44 | Initiates | → Perform | Get Alert |
| 09/05/2019 | INCY | Buy Now | Incyte | $68.25 | 46.52% | Jay Olson60% | $85 → $100 | Upgrade | Perform → Outperform | Get Alert |
| 09/03/2019 | MDCO | Buy Now | Medicines Co | — | — | Jay Olson60% | $52 → $60 | Maintains | Outperform | Get Alert |
| 08/13/2019 | MLND | Buy Now | Millendo Therapeutics | — | — | Jay Olson60% | $26 → $25 | Maintains | Outperform | Get Alert |
| 08/13/2019 | AMGN | Buy Now | Amgen | $289.33 | -20.51% | Jay Olson60% | $210 → $230 | Maintains | Outperform | Get Alert |
| 07/16/2019 | MLND | Buy Now | Millendo Therapeutics | — | — | Jay Olson60% | → $26 | Initiates | → Outperform | Get Alert |
| 11/19/2018 | ICPT | Buy Now | Intercept Pharma | — | — | Jay Olson60% | → $140 | Upgrade | Perform → Outperform | Get Alert |
| 08/08/2018 | ENTA | Buy Now | Enanta Pharma | $7.18 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 07/18/2018 | INCY | Buy Now | Incyte | $68.25 | 2.56% | Jay Olson60% | $65 → $70 | Maintains | Perform | Get Alert |
| 06/01/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | — | Jay Olson60% | — | Upgrade | Perform → Outperform | Get Alert |
| 05/24/2018 | ENTA | Buy Now | Enanta Pharma | $7.18 | 1780.22% | Jay Olson60% | → $135 | Initiates | → Outperform | Get Alert |
| 04/24/2018 | PRTA | Buy Now | Prothena Corp | $5.64 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 04/17/2018 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.73 | -54.5% | Jay Olson60% | → $130 | Initiates | → Perform | Get Alert |
| 03/20/2018 | MDWD | Buy Now | MediWound | $19.09 | -37.14% | Jay Olson60% | $10 → $12 | Maintains | Outperform | Get Alert |
| 01/31/2018 | ACOR | Buy Now | Acorda Therapeutics | — | — | Jay Olson60% | $18 → $21 | Maintains | Perform | Get Alert |
| 01/26/2018 | BIIB | Buy Now | Biogen | $127.04 | 214.86% | Jay Olson60% | $380 → $400 | Maintains | Outperform | Get Alert |
| 11/30/2017 | MDCO | Buy Now | Medicines Co | — | — | Jay Olson60% | — | Upgrade | Perform → Outperform | Get Alert |
| 11/09/2017 | ACOR | Buy Now | Acorda Therapeutics | — | — | Jay Olson60% | → $27 | Initiates | → Perform | Get Alert |
| 11/09/2017 | BIIB | Buy Now | Biogen | $127.04 | 175.5% | Jay Olson60% | → $350 | Initiates | → Outperform | Get Alert |
| 11/02/2017 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -32.83% | Jay Olson60% | $70 → $85 | Maintains | Outperform | Get Alert |
| 09/22/2017 | ICPT | Buy Now | Intercept Pharma | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 07/11/2017 | TXMD | Buy Now | TherapeuticsMD | $1.08 | — | Jay Olson60% | — | Upgrade | Perform → Outperform | Get Alert |
| 06/23/2017 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Jay Olson60% | → $8 | Initiates | → Outperform | Get Alert |
| 06/14/2017 | NDRM | Buy Now | NeuroDerm Ltd. - Ordinary Shares | — | — | Jay Olson60% | → $42 | Upgrade | Perform → Outperform | Get Alert |
| 05/22/2017 | MDCO | Buy Now | Medicines Co | — | — | Jay Olson60% | → $50 | Initiates | → Perform | Get Alert |
| 05/12/2017 | INCY | Buy Now | Incyte | $68.25 | 83.15% | Jay Olson60% | → $125 | Initiates | → Market Perform | Get Alert |
| 05/09/2017 | TXMD | Buy Now | TherapeuticsMD | $1.08 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 03/07/2017 | NDRM | Buy Now | NeuroDerm Ltd. - Ordinary Shares | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 02/24/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Jay Olson60% | — | Upgrade | Perform → Outperform | Get Alert |
| 01/27/2017 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | — | Jay Olson60% | — | Upgrade | Perform → Outperform | Get Alert |
| 01/19/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Jay Olson60% | → $28 | Initiates | → Perform | Get Alert |
| 12/13/2016 | AMGN | Buy Now | Amgen | $289.33 | -42.63% | Jay Olson60% | → $166 | Initiates | → Outperform | Get Alert |
| 11/22/2016 | TXMD | Buy Now | TherapeuticsMD, Inc. Common Stock | $1.08 | 1011.11% | Jay Olson60% | → $12 | Initiates | → Outperform | Get Alert |
| 11/22/2016 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -56.54% | Jay Olson60% | → $55 | Initiates | → Perform | Get Alert |
| 08/05/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Jay Olson60% | $265 → $250 | Maintains | Outperform | Get Alert |
| 06/14/2016 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 03/10/2016 | ZFC | Buy Now | ZAIS Financial | — | — | Jay Olson60% | $17 → $16 | Maintains | Outperform | Get Alert |
| 03/09/2016 | IILG | Buy Now | Interval Leisure Group | — | — | Jay Olson60% | — | Initiates | → Outperform | Get Alert |
| 02/12/2016 | INCY | Buy Now | Incyte | $68.25 | 58.24% | Jay Olson60% | $129 → $108 | Maintains | Outperform | Get Alert |
| 04/27/2015 | BIIB | Buy Now | Biogen | $127.04 | — | Jay Olson60% | — | Assumes | → Perform | Get Alert |
| 02/23/2015 | INCY | Buy Now | Incyte | $68.25 | 30.4% | Jay Olson60% | $75 → $89 | Maintains | Outperform | Get Alert |
| 09/09/2014 | MRNS | Buy Now | Marinus Pharma | — | — | Jay Olson60% | → $12 | Initiates | → Outperform | Get Alert |
| 07/11/2014 | PRTA | Buy Now | Prothena Corp | $5.64 | 609.18% | Jay Olson60% | → $40 | Initiates | → Outperform | Get Alert |
| 07/10/2014 | PRTA | Buy Now | Prothena Corp | $5.64 | 609.18% | Jay Olson60% | → $40 | Initiates | → Outperform | Get Alert |
| 01/10/2014 | ICPT | Buy Now | Intercept Pharma | — | — | Jay Olson60% | $94 → $360 | Maintains | Outperform | Get Alert |
| 08/02/2013 | INCY | Buy Now | Incyte | $68.25 | -58.97% | Jay Olson60% | $25 → $28 | Maintains | Outperform | Get Alert |
| 06/20/2013 | ICPT | Buy Now | Intercept Pharma | — | — | Jay Olson60% | → $60 | Initiates | → Outperform | Get Alert |
| 06/20/2013 | MDCO | Buy Now | Medicines Co | — | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/18/2013 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -87.36% | Jay Olson60% | → $16 | Initiates | → Outperform | Get Alert |
| 01/03/2013 | BIIB | Buy Now | Biogen | $127.04 | 10.99% | Jay Olson60% | $145 → $141 | Maintains | Perform | Get Alert |
| 11/19/2012 | MDCO | Buy Now | Medicines Co | — | — | Jay Olson60% | → $35 | Initiates | → Outperform | Get Alert |
| 10/24/2012 | AMGN | Buy Now | Amgen | $289.33 | -69.24% | Jay Olson60% | $85 → $89 | Maintains | Perform | Get Alert |
| 10/04/2012 | BIIB | Buy Now | Biogen | $127.04 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/01/2012 | BIIB | Buy Now | Biogen Idec | $127.04 | 9.41% | Jay Olson60% | $136 → $139 | Maintains | Outperform | Get Alert |
| 04/25/2012 | BIIB | Buy Now | Biogen Idec | $127.04 | 7.05% | Jay Olson60% | $127 → $136 | Maintains | Outperform | Get Alert |
| 02/09/2012 | AMGN | Buy Now | Amgen | $289.33 | — | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
